What is the Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition?
The Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition (2023) is a practical clinical reference covering systemic medications used in dermatological practice. It explains drug mechanisms, indications, dosages, contraindications, interactions, adverse effects, and monitoring, making it a useful resource for dermatologists, physicians, pharmacists, specialist nurses, and medical trainees.
Introduction
Systemic medications play an important role in the management of many dermatological conditions. From inflammatory skin diseases and severe acne to autoimmune disorders, infections, and skin malignancies, effective treatment frequently requires more than topical therapy alone.
However, prescribing systemic dermatological medications involves important clinical responsibilities. Healthcare professionals must understand the pharmacological properties of each medication, select appropriate treatment regimens, recognize contraindications, anticipate adverse reactions, and establish suitable monitoring plans.
The Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition addresses these practical challenges by providing a concise and organized reference for prescribing and monitoring systemic treatments used in dermatology.
Edited by Sarah H. Wakelin, Howard I. Maibach, and Clive B. Archer, this revised edition was published in 2023 by CRC Press. It brings together contributions from numerous specialists and covers a broad range of medications used in contemporary dermatological practice.
One of the book's most valuable characteristics is its practical approach to pharmacotherapy. Rather than focusing exclusively on the theoretical aspects of medications, it provides clinically relevant information that helps healthcare professionals understand how systemic treatments are selected, prescribed, and monitored.
The third edition also reflects developments in dermatological therapeutics, including newer biological therapies and Janus kinase (JAK) inhibitors, alongside updated information concerning established medications.
Whether you are a medical student developing your understanding of dermatological pharmacology, a resident managing patients with complex skin conditions, or an experienced dermatologist looking for a convenient prescribing reference, this handbook offers a structured approach to systemic drug treatment.
Book Overview
|
Book detail |
Information |
|
Full
title |
Handbook of Systemic Drug Treatment
in Dermatology |
|
Edition |
Third Edition |
|
Publication
year |
2023 |
|
Editors |
Sarah H. Wakelin, Howard I. Maibach,
Clive B. Archer |
|
Publisher |
CRC Press |
|
Publisher
imprint |
Informa UK Limited |
|
Medical
specialty |
Dermatology |
|
Main
subject |
Systemic dermatological
pharmacotherapy |
|
Number
of chapters |
41 |
|
ISBN
(Hardback) |
9780367860820 |
|
ISBN
(Paperback) |
9780367860813 |
|
ISBN
(eBook) |
9781003016786 |
|
DOI |
10.1201/9781003016786 |
Intended audience: Dermatologists, family practitioners, pharmacists, specialist nurses, medical students, residents, and other healthcare professionals involved in prescribing or monitoring systemic dermatological treatments.
WHAT THIS BOOK COVERS
The handbook is organized into 41 chapters, each addressing a particular medication, drug class, or important clinical consideration associated with systemic dermatological treatment.
Its broad coverage makes it useful for understanding both established therapies and newer treatment approaches.
1. Systemic Retinoids and Acne Treatments
The opening chapters introduce several important medications used in dermatology, including:
- Acitretin
- Acne antibiotics
- Alitretinoin
- Isotretinoin
These chapters address the pharmacological properties and dermatological applications of these treatments.
For example, the acitretin chapter discusses its role in psoriasis and severe disorders of keratinization. It also addresses pregnancy-related precautions, baseline investigations, monitoring requirements, contraindications, and clinically important drug interactions.
The acne antibiotic chapter examines medications such as doxycycline, lymecycline, minocycline, erythromycin, and trimethoprim.
It also discusses antibiotic resistance, treatment duration, combination therapy, and the importance of antimicrobial stewardship.
These subjects are particularly relevant to clinicians managing inflammatory acne and patients requiring systemic retinoid therapy.
2. Antibiotics, Antifungals, Antivirals, and Antiparasitic Treatments
Several chapters focus on systemic medications used to manage infectious dermatological conditions.
Topics include:
- Antibiotics commonly used for skin infections.
- Systemic antifungal medications.
- Antimalarial drugs.
- Antiviral treatments for herpesvirus infections.
- Ivermectin.
- Azole antihelminths.
The coverage includes medications used in bacterial, fungal, viral, and parasitic skin diseases.
These chapters are useful for understanding the pharmacological options available for infectious dermatological conditions and the prescribing considerations associated with individual drug classes.
3. Immunosuppressive and Immunomodulatory Medications
An important part of the handbook addresses systemic therapies that modify immune responses.
The relevant chapters include:
- Azathioprine.
- Ciclosporin.
- Corticosteroids.
- Cyclophosphamide.
- Dapsone.
- Methotrexate.
- Mycophenolate mofetil.
- Dimethyl fumarate.
- Rituximab.
- Intravenous immunoglobulin.
These medications are relevant to the management of various inflammatory, autoimmune, and immunologically mediated skin diseases.
The handbook also addresses practical prescribing issues, including adverse effects, contraindications, interactions, and the investigations required before and during treatment.
This information is particularly important when prescribing medications with significant immunosuppressive or toxicity profiles.
4. Biological Therapies and Targeted Treatments
The third edition includes several chapters covering modern targeted therapies used in dermatology.
These include:
- Interleukin-4/13 inhibitors.
- Interleukin-12/23 and interleukin-23 inhibitors.
- Interleukin-17 inhibitors.
- Janus kinase (JAK) inhibitors.
- Tumor necrosis factor antagonists.
- Omalizumab.
These treatment categories represent important developments in the pharmacological management of inflammatory skin diseases.
The inclusion of dedicated chapters on these therapies makes the handbook particularly relevant to clinicians interested in contemporary psoriasis, eczema, and urticaria treatment.
It also provides a useful opportunity for trainees to become familiar with the different categories of targeted systemic medications.
5. Dermatological Oncology and Anticancer Treatments
The handbook includes dedicated chapters on systemic treatments used in dermatological oncology.
These cover:
- Malignant melanoma drug treatments.
- Bexarotene.
- Vismodegib.
- Selected targeted anticancer medications discussed within the melanoma chapter.
These subjects introduce important pharmacological approaches to managing malignant skin diseases and selected cutaneous malignancies.
For clinicians interested in dermatological oncology, these chapters provide an overview of relevant systemic treatment categories.
6. Other Important Dermatological Medications
Additional chapters address several medications with specific dermatological applications:
- Antiandrogens.
- Apremilast.
- Colchicine.
- Potassium iodide.
- Propranolol.
- Psoralens.
- Sulfapyridine and sulfamethoxypyridazine.
- Thalidomide.
Together, these chapters expand the handbook's coverage beyond the most frequently discussed systemic dermatological treatments.
7. Systemic Treatment in Special Patient Populations
One particularly useful aspect of the third edition is its attention to patients who require additional prescribing considerations.
The final chapters cover:
- Systemic therapy in children and young people.
- Systemic therapy and kidney disease.
- Systemic therapy and liver disease.
- Systemic therapy in older people.
These chapters address important clinical challenges associated with prescribing systemic medications in patients with different physiological characteristics and comorbidities.
For example, renal impairment can affect the elimination of medications and increase the risk of drug accumulation. Similarly, liver disease may influence the safety and monitoring requirements of potentially hepatotoxic treatments.
The chapter on older people also addresses the challenges associated with frailty, polypharmacy, altered drug handling, and adverse drug reactions.
These subjects are especially relevant to safe and individualized prescribing.
Key Features
The Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition offers several useful educational and practical features:
- Comprehensive medication coverage: Includes 41 chapters covering individual drugs, medication classes, and special prescribing situations.
- Classification and mode of action: Explains the pharmacological characteristics of the medications discussed.
- Clinical indications: Describes the dermatological conditions for which systemic treatments are used.
- Dosages and suggested regimens: Provides practical prescribing information.
- Baseline investigations: Addresses investigations and considerations before initiating selected treatments.
- Monitoring recommendations: Discusses monitoring requirements during treatment.
- Contraindications and cautions: Highlights serious situations in which particular medications should be avoided or prescribed carefully.
- Drug interactions: Provides information about clinically relevant interactions.
- Adverse effects: Discusses potential unwanted effects and their management.
- Patient information: Includes important counselling considerations.
- Special populations: Covers prescribing considerations in children, older adults, and patients with kidney or liver disease.
- Updated therapeutic coverage: Includes newer medication categories and updated information on established therapies.
Who Should Read This Book?
Medical Students
Medical students interested in dermatology can use this handbook to develop their understanding of systemic dermatological pharmacology.
It introduces important drug classes, their mechanisms of action, indications, contraindications, and adverse effects.
It can also help students appreciate why selecting a medication involves more than simply identifying the disease being treated.
Dermatology Residents
Dermatology residents are among the readers most likely to benefit from this handbook.
During residency, trainees encounter patients requiring treatments such as methotrexate, ciclosporin, retinoids, biologics, and other systemic medications.
The book provides a structured reference for reviewing the practical aspects of these treatments.
Practicing Dermatologists and Specialists
Dermatologists can use the handbook as a convenient reference when considering systemic treatment options.
Its organized drug-specific chapters are particularly useful when reviewing prescribing precautions, monitoring requirements, and potential interactions.
Other specialists involved in the care of patients receiving systemic dermatological treatments may also find relevant information.
Pharmacists
Pharmacists are an explicitly identified audience for the handbook.
Its coverage of formulations, drug interactions, contraindications, and adverse effects makes it relevant to medication review and prescribing support.
Postgraduate and Board Examination Candidates
The book may also serve as a supplementary learning resource for postgraduate examinations in dermatology and related specialties.
Its coverage of drug mechanisms, indications, adverse effects, and contraindications provides useful material for reviewing dermatological pharmacology.
It is a clinical reference rather than a dedicated examination question bank or revision textbook.
Why This Book is Useful
1. A Practical Approach to Clinical Prescribing
One of the central objectives of the handbook is to support rational medication decisions while considering treatment risks and unwanted effects.
Its organization around individual medications and drug classes makes it easier to locate relevant prescribing information.
Rather than presenting pharmacology as an isolated theoretical subject, the book connects medication information with practical dermatological treatment.
2. Attention to Medication Safety
Safe prescribing requires a thorough understanding of potential adverse effects, contraindications, and drug interactions.
The handbook gives these subjects considerable attention.
For example, its acitretin chapter discusses teratogenicity, lipid abnormalities, liver monitoring, and important interactions with other medications.
Similarly, its discussion of systemic immunosuppressive treatments addresses baseline investigations and ongoing monitoring.
This emphasis makes medication safety an important part of the book's educational value.
3. Understanding Treatment Monitoring
Monitoring is an essential component of systemic dermatological therapy.
Depending on the medication, clinicians may need to assess blood counts, renal function, liver function, lipid levels, or other relevant parameters.
The handbook discusses these considerations within individual drug chapters and dedicated sections on special populations.
This can help trainees understand why monitoring requirements differ between medications.
4. Coverage of Modern Dermatological Treatments
Dermatological pharmacotherapy has changed considerably since the publication of the second edition in 2015.
The third edition reflects the introduction of newer biological treatments and JAK inhibitors, alongside developments in prescribing established therapies.
This makes it useful for readers seeking an overview of several important therapeutic developments in contemporary dermatology.
5. Understanding Complex Patients
Not all patients can receive systemic dermatological treatments under the same conditions.
Age, kidney function, liver function, comorbidities, and concurrent medications may influence treatment selection.
The dedicated chapters on children, older adults, kidney disease, and liver disease address these important considerations.
6. Supplementary Examination Preparation
For postgraduate learners, reviewing drug mechanisms, contraindications, interactions, and adverse effects is an important part of developing clinical knowledge.
The handbook can support this learning process by providing a structured overview of systemic dermatological pharmacology.
Nevertheless, candidates should combine it with specialty textbooks, clinical guidelines, and dedicated examination resources.
Table of Contents Overview
The third edition contains 41 chapters organized as follows:
|
Chapter |
Subject |
|
1 |
Acitretin |
|
2 |
Acne Antibiotics |
|
3 |
Alitretinoin |
|
4 |
Antiandrogens |
|
5 |
Antibiotics Commonly Used for Skin
Infections |
|
6 |
Antifungals |
|
7 |
Antimalarials |
|
8 |
Antivirals for Herpesviruses |
|
9 |
Apremilast |
|
10 |
Azathioprine |
|
11 |
Azole Antihelminths |
|
12 |
Bexarotene |
|
13 |
Ciclosporin |
|
14 |
Colchicine |
|
15 |
Corticosteroids |
|
16 |
Cyclophosphamide |
|
17 |
Dapsone |
|
18 |
Dimethyl Fumarate |
|
19 |
Interleukin-4/13 Inhibitors |
|
20 |
Interleukin-12/23 and IL-23
Inhibitors |
|
21 |
Interleukin-17 Inhibitors |
|
22 |
Isotretinoin |
|
23 |
Ivermectin |
|
24 |
Intravenous Immunoglobulin |
|
25 |
Janus Kinase (JAK) Inhibitors |
|
26 |
Malignant Melanoma Drug Treatments |
|
27 |
Methotrexate |
|
28 |
Mycophenolate Mofetil |
|
29 |
Omalizumab |
|
30 |
Potassium Iodide |
|
31 |
Propranolol |
|
32 |
Psoralens |
|
33 |
Rituximab |
|
34 |
Sulfapyridine and
Sulfamethoxypyridazine |
|
35 |
Thalidomide |
|
36 |
Tumour Necrosis Factor Antagonists |
|
37 |
Vismodegib |
|
38 |
Systemic Therapy in Children and
Young People |
|
39 |
Systemic Therapy and Kidney Disease |
|
40 |
Systemic Therapy and Liver Disease |
|
41 |
Systemic Therapy in Older People |
The handbook also includes a preface, contributor information, a list of abbreviations, and an extensive index.
Strengths of the Book
Several characteristics make this third edition a useful reference for healthcare professionals.
1. Broad Coverage of Systemic Dermatological Pharmacotherapy
The book covers a wide range of medication categories, from conventional systemic treatments to biological and targeted therapies.
This breadth makes it relevant to different areas of dermatological practice.
2. Consistent Organization of Drug Information
The individual medication chapters follow a practical structure that addresses classification, mechanism of action, indications, formulations, dosages, monitoring, contraindications, interactions, and adverse effects.
This consistent organization helps readers locate information without having to navigate an entirely different structure in every chapter.
3. Contributions From Multiple Specialists
The third edition includes contributions from numerous clinicians and specialists working in dermatology and related fields.
The contributor list includes professionals associated with institutions such as Imperial College Healthcare NHS Trust, St John's Institute of Dermatology, the University of Manchester, and the University of California School of Medicine.
This multidisciplinary authorship is a notable academic feature.
4. Emphasis on Safe Prescribing
The book repeatedly highlights the importance of recognizing treatment risks and monitoring patients appropriately.
Its coverage of special populations is particularly valuable because systemic treatment decisions may become more complicated in patients with renal impairment, liver disease, advanced age, or childhood.
5. Updated Third Edition
The editors explain that the third edition incorporates newer medications and updated information on established treatments.
The inclusion of biological therapies and JAK inhibitors is particularly relevant to the changing landscape of dermatological pharmacotherapy.
Limitations
Although the handbook offers broad coverage, readers should consider several points when using it.
1. It is not a replacement for current prescribing guidance.
The editors explicitly advise clinicians to verify doses and recommendations using current formularies and manufacturers' information.
This is particularly important because medication licensing, safety recommendations, and treatment guidelines can change.
2. It is primarily a prescribing reference.
The book concentrates on systemic medication treatment rather than providing a comprehensive textbook covering every aspect of dermatological diagnosis, clinical examination, histopathology, and procedural dermatology.
Readers seeking those subjects will need additional specialty resources.
3. Some chapters require supplementary clinical guidance.
The handbook provides detailed medication information, but individual treatment decisions still require consideration of patient history, clinical circumstances, and relevant professional guidelines.
4. It is not a dedicated examination preparation book.
Although its pharmacological content can support postgraduate learning, the contents do not identify it as a question bank or comprehensive board examination revision resource.
5. Comparative evaluations are not provided.
The book discusses individual treatments and selected comparisons within specific chapters, but it does not present a comprehensive comparison of itself against other dermatology textbooks.
Comparison With Similar Books
The Handbook of Systemic Drug Treatment in Dermatology has a focused educational purpose: systemic dermatological pharmacotherapy and safe prescribing.
Its organization around medications, rather than primarily around individual skin diseases, gives it a distinct reference-oriented approach.
For readers comparing dermatology resources, it is important to distinguish between three broad educational needs:
- General dermatology textbooks: Primarily support learning about skin diseases, diagnosis, clinical presentation, and management.
- Dermatological pharmacology references: Concentrate on medications, mechanisms of action, indications, dosages, adverse effects, and interactions.
- Clinical guidelines: Provide recommendations for managing particular conditions and should be checked for current updates.
This handbook belongs primarily to the second category, while also incorporating practical clinical considerations.
Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition
Or: Link 2
FAQs
It is a clinical reference covering systemic medications used in dermatological practice. It discusses drug classifications, mechanisms of action, indications, formulations, dosages, contraindications, interactions, adverse effects, and monitoring requirements.
The third edition was edited by Sarah H. Wakelin, Howard I. Maibach, and Clive B. Archer. It was published by CRC Press in 2023.
The book covers systemic retinoids, antibiotics, antifungals, antimalarials, antivirals, immunosuppressants, biological therapies, JAK inhibitors, melanoma drug treatments, and other medications used in dermatology. It also addresses systemic treatment in children, older adults, and patients with kidney or liver disease.
Yes. Dedicated chapters cover several biological treatment categories, including interleukin-4/13 inhibitors, interleukin-12/23 and IL-23 inhibitors, interleukin-17 inhibitors, and tumour necrosis factor antagonists. The handbook also discusses JAK inhibitors and other targeted treatments.
Yes. Its structured discussions of medication indications, mechanisms, dosages, contraindications, interactions, adverse effects, and monitoring make it a useful supplementary reference for dermatology residents.
Yes. Monitoring requirements and adverse effects are important components of the individual medication chapters. The book also addresses baseline investigations, contraindications, and clinically significant drug interactions.
Yes. Chapter 38 covers systemic therapy in children and young people, while Chapter 41 addresses systemic treatment in older people. Separate chapters also discuss prescribing in patients with kidney and liver disease.
No. The handbook is intended as a supplementary professional reference. Its editors specifically recommend independently verifying doses and clinical recommendations using current national formularies, manufacturer information, and appropriate professional guidelines before prescribing.
Conclusion
The Handbook of Systemic Drug Treatment in Dermatology, 3rd Edition (2023) is a valuable clinical reference for healthcare professionals interested in the safe and effective use of systemic dermatological medications.
Its 41 chapters provide broad coverage of conventional systemic treatments, immunosuppressive medications, biological therapies, targeted drugs, and selected treatments for dermatological malignancies.
One of its greatest strengths is its practical organization. By addressing medication mechanisms, indications, dosages, contraindications, interactions, adverse effects, and monitoring, the handbook helps connect pharmacological knowledge with the everyday responsibilities of clinical prescribing.
Its dedicated discussions of treatment in children, older adults, and patients with kidney or liver disease further strengthen its usefulness as a professional reference.
For medical students, dermatology residents, practicing dermatologists, pharmacists, and specialist nurses, this third edition offers an organized way to review systemic dermatological pharmacotherapy.
Although it should always be supplemented by current prescribing guidelines and updated drug information, it remains a relevant educational resource for understanding the medications used in modern dermatological practice.
For readers looking for a focused reference on systemic drug treatment in dermatology, this handbook deserves consideration.
.webp)